Eating less dials down the hidden inflammation that ages you
Scientists have known for decades that cutting calories extends lifespan in mice.
The CALERIE trial is one of the few long-term, controlled studies of caloric restriction in healthy humans. Participants ate roughly 14 percent fewer calories than usual for two years. Researchers applied proteomics — a technique that maps thousands of proteins simultaneously — to longitudinal plasma samples and compared them with a control group eating normally. What they found adds important detail to one of aging biology’s most stubborn puzzles: the low-grade chronic inflammation that quietly accelerates aging, known as inflammaging.
Inflammaging is not the kind of inflammation you feel after a cut or infection. It’s a permanent background hum of immune activation that slowly damages tissues and organs over years. It’s been linked to virtually every major age-related disease: cardiovascular disease, dementia, type 2 diabetes, cancer. The problem is that it’s hard to measure and even harder to interrupt.
A protein hiding in belly fat
The team identified complement protein C3a as a key driver. C3a is part of the complement system — a branch of the immune system normally tasked with clearing bacteria and damaged cells. In aging, this system becomes overactive. The study showed that caloric restriction significantly reduced C3a activity in participants who ate less.
To understand the source, the researchers turned to old mice. They found that C3a is produced primarily by macrophages — immune cells — in visceral fat, the deep abdominal fat wrapped around organs. That fat depot has long been associated with inflammation in aging. Critically, when the researchers neutralized C3a in old mice, inflammaging dropped substantially. The chronic inflammation wasn’t inevitable — it could be interrupted.
Could a drug do what a diet does?
The finding offers a possible explanation for why caloric restriction has such broad effects on aging. Rather than targeting one specific disease, it appears to suppress a fundamental inflammatory mechanism. That makes C3a an appealing drug target — a molecule that could potentially mimic the effects of eating less without anyone having to count a single calorie.
Caveats apply. CALERIE was relatively small, the calorie reduction was modest, and participants were healthy adults without obesity. Whether the same mechanisms operate in people with excess weight, elderly individuals with multiple conditions, or under stricter restriction remains unknown. And whether long-term C3a inhibition is safe is an open question — the complement system has critical protective functions, and interfering with it carries real risks. The distance between a promising mechanism and a usable therapy is rarely short.